(Q38303192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

State of the art of immunoassay methods for B-type natriuretic peptides: An update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Claudio Passino

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1

Aldo Clerico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

4

Concetta Prontera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Silvia Masotti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

30 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Clinical Laboratory Sciences

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

56-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Use of natriuretic peptides to guide and monitor heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Natriuretic peptide-guided heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Quality specifications for B-type natriuretic peptide assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The precursor to B-type natriuretic peptide is an O-linked glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

BNP molecular forms and processing by the cardiac serine protease corin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Complexity of molecular forms of B-type natriuretic peptide in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Assay for measurement of intact B-type natriuretic peptide prohormone in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Plasma soluble corin in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Corin in clinical laboratory diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Performance characteristics of four automated natriuretic peptide assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Clinical value of NT-ProBNP and BNP in pediatric cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Cardiovascular aging and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Possibility of age regulation of the natriuretic peptide C-receptor in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Reference change values for brain natriuretic peptides revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Heart failure biomarkers at point-of-care: current utilization and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Primary results of the HABIT Trial (heart failure assessment with BNP in the home).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.987720

10.3109/10408363.2014.987720

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25547534%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference